Humanized Mouse and Rat Model Market Report – Research, Industry Analysis Reports and Market Demands

Global Humanized Mouse and Rat Model Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Humanized Mouse and Rat Model Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Humanized Mouse and Rat Model Market Size Growth Rate by Product
- 1.4.2 Genetic
- 1.4.3 Cell-Based
1.5 Market by End User
- 1.5.1 Global Humanized Mouse and Rat Model Market Size Growth Rate by End User
- 1.5.2 Pharmaceutical
- 1.5.3 Biotechnology Companies
- 1.5.4 CRO
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Humanized Mouse and Rat Model Market Size
- 2.1.1 Global Humanized Mouse and Rat Model Revenue 2014-2025
- 2.1.2 Global Humanized Mouse and Rat Model Sales 2014-2025
2.2 Humanized Mouse and Rat Model Growth Rate by Regions
- 2.2.1 Global Humanized Mouse and Rat Model Sales by Regions
- 2.2.2 Global Humanized Mouse and Rat Model Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Humanized Mouse and Rat Model Sales by Manufacturers
- 3.1.1 Humanized Mouse and Rat Model Sales by Manufacturers
- 3.1.2 Humanized Mouse and Rat Model Sales Market Share by Manufacturers
- 3.1.3 Global Humanized Mouse and Rat Model Market Concentration Ratio (CR5 and HHI)
3.2 Humanized Mouse and Rat Model Revenue by Manufacturers
- 3.2.1 Humanized Mouse and Rat Model Revenue by Manufacturers (2014-2019)
- 3.2.2 Humanized Mouse and Rat Model Revenue Share by Manufacturers (2014-2019)
3.3 Humanized Mouse and Rat Model Price by Manufacturers
3.4 Humanized Mouse and Rat Model Manufacturing Base Distribution, Product Types
- 3.4.1 Humanized Mouse and Rat Model Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Humanized Mouse and Rat Model Product Type
- 3.4.3 Date of International Manufacturers Enter into Humanized Mouse and Rat Model Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Humanized Mouse and Rat Model Sales by Product
4.2 Global Humanized Mouse and Rat Model Revenue by Product
4.3 Humanized Mouse and Rat Model Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Humanized Mouse and Rat Model Breakdown Data by End User

6 North America

6.1 North America Humanized Mouse and Rat Model by Countries
- 6.1.1 North America Humanized Mouse and Rat Model Sales by Countries
- 6.1.2 North America Humanized Mouse and Rat Model Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Humanized Mouse and Rat Model by Product
6.3 North America Humanized Mouse and Rat Model by End User

7 Europe

7.1 Europe Humanized Mouse and Rat Model by Countries
- 7.1.1 Europe Humanized Mouse and Rat Model Sales by Countries
- 7.1.2 Europe Humanized Mouse and Rat Model Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Humanized Mouse and Rat Model by Product
7.3 Europe Humanized Mouse and Rat Model by End User

8 Asia Pacific

8.1 Asia Pacific Humanized Mouse and Rat Model by Countries
- 8.1.1 Asia Pacific Humanized Mouse and Rat Model Sales by Countries
- 8.1.2 Asia Pacific Humanized Mouse and Rat Model Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Humanized Mouse and Rat Model by Product
8.3 Asia Pacific Humanized Mouse and Rat Model by End User

9 Central & South America

9.1 Central & South America Humanized Mouse and Rat Model by Countries
- 9.1.1 Central & South America Humanized Mouse and Rat Model Sales by Countries
- 9.1.2 Central & South America Humanized Mouse and Rat Model Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Humanized Mouse and Rat Model by Product
9.3 Central & South America Humanized Mouse and Rat Model by End User

10 Middle East and Africa

10.1 Middle East and Africa Humanized Mouse and Rat Model by Countries
- 10.1.1 Middle East and Africa Humanized Mouse and Rat Model Sales by Countries
- 10.1.2 Middle East and Africa Humanized Mouse and Rat Model Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Humanized Mouse and Rat Model by Product
10.3 Middle East and Africa Humanized Mouse and Rat Model by End User

11 Company Profiles

12 Future Forecast

12.1 Humanized Mouse and Rat Model Market Forecast by Regions
- 12.1.1 Global Humanized Mouse and Rat Model Sales Forecast by Regions 2019-2025
- 12.1.2 Global Humanized Mouse and Rat Model Revenue Forecast by Regions 2019-2025
12.2 Humanized Mouse and Rat Model Market Forecast by Product
- 12.2.1 Global Humanized Mouse and Rat Model Sales Forecast by Product 2019-2025
- 12.2.2 Global Humanized Mouse and Rat Model Revenue Forecast by Product 2019-2025
12.3 Humanized Mouse and Rat Model Market Forecast by End User
12.4 North America Humanized Mouse and Rat Model Forecast
12.5 Europe Humanized Mouse and Rat Model Forecast
12.6 Asia Pacific Humanized Mouse and Rat Model Forecast
12.7 Central & South America Humanized Mouse and Rat Model Forecast
12.8 Middle East and Africa Humanized Mouse and Rat Model Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Humanized Mouse and Rat Model Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
The global Humanized Mouse and Rat Model market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Humanized Mouse and Rat Model market based on company, product type, end user and key regions.

This report studies the global market size of Humanized Mouse and Rat Model in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Humanized Mouse and Rat Model in these regions.
This research report categorizes the global Humanized Mouse and Rat Model market by top players/brands, region, type and end user. This report also studies the global Humanized Mouse and Rat Model market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)

Market size by Product
Genetic
Cell-Based
Market size by End User
Pharmaceutical
Biotechnology Companies
CRO

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Humanized Mouse and Rat Model market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Humanized Mouse and Rat Model market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Humanized Mouse and Rat Model companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Humanized Mouse and Rat Model submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Humanized Mouse and Rat Model are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Humanized Mouse and Rat Model market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.